#JPM21: Albert Bourla prepares Pfizer to settle in to next phase post-Upjohn, but that doesn't mean he's ruling out deals

One of the iconic brands in biopharma, Pfizer took a big gamble on the strength of its in-house science when it decided to

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

#JPM21: Al­bert Bourla pre­pares Pfiz­er to set­tle in to next phase post-Up­john, but that does­n't mean he's rul­ing out deals